**Author details**

Subramanian Kalaivani Selvi1 \*, B.H. Srinivas2 and Sadhanandham Shrinuvasan3

1 Department of Pathology, Sri Manakula Vinayagar Medical College and Hospital, Puducherry, India

2 Department of Pathology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India

3 Department of Radiology, Indira Gandhi Medical College and Research Institute, Puducherry, India

\*Address all correspondence to: klvnselvi@yahoo.co.in

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**69**

381-429

*B-Cell Lymphomas*

**References**

*DOI: http://dx.doi.org/10.5772/intechopen.87370*

based on a survey of 253 cases. Cancer.

[11] Preud'homme JL, Seligmann M. Surface bound immunoglobulins

lymphoproliferative diseases. Blood.

[12] Lennert K, Stein H, Kaiserling E. Cytological and functional criteria for the classification of malignant lymphomata. British Journal of Cancer.

[13] Lukes RJ, Collins RD. Immunologic

[15] Korsmeyer SJ, Hieter PA, Ravetch JV, et al. Developmental hierarchy of immunoglobulin gene rearrangements in human leukemic pre-B-cells. Proceedings of the National Academy of Sciences of the United States of America. 1981;**78**:7096-7100

[16] Reis MD, Griesser H, Mak TW. T cell receptor and immunoglobulin gene rearrangements in lymphoproliferative disorders. Advances in Cancer Research.

[17] Waldmann TA, Davis MM,

Bongiovanni KF, et al. Rearrangements of genes for the antigen receptor on

[10] Aisenberg AC, Bloch KJ. Immunoglobulins on the surface of neoplastic lymphocytes. The New England Journal of Medicine.

as a cell marker in human

1975;**31**(Suppl. 2):29-43

1985;**313**:529-533

1989;**52**:45-80

characterization of human malignant lymphomas. Cancer. 1974;**34**(Suppl):1488-1503

[14] Aisenberg AC, Krontiris TG, Mak TW, et al. Rearrangement of the gene for the beta chain of the T-cell receptor in T-cell chronic lymphocytic leukemia and related disorders. The New England Journal of Medicine.

1956;**9**:792-821

1972;**287**:272-276

1972;**40**:777-794

[2] McCurley TL, Macon WR. Diagnosis and classification of non-Hodgkin lymphomas. In: Greer JP, Foerster J, Lukens JN, editors. Wintrobe's Clinical Hematology. 11th ed. Lippincott Williams & Wilkins Publishers; 2003.

[3] Baris D, Zahm SH. Epidemiology of lymphomas. Current Opinion in

Oncology. 2000;**12**:383-394

[4] Hodgkin T. On some morbid appearances of the absorbent glands and spleen. Transactions on the Royal Medico-Chirurgical Society of Glasgow.

[5] Kundrat H. Ueber Lympho-Sarkomatosis. Wiener Klinische Wochenschrift. 1893;**6**:211-234

verlaufende Tuberculose des lymphateschen Apparates. Ztschr f

[7] Reed DM. On the pathological changes in Hodgkin's disease, with especial reference to its relation to tuberculosis. The Johns Hopkins Medical Journal. 1902;**10**:133-196

[8] Gall EA, Mallory TB. Malignant lymphoma: A clinico-pathological survey of 618 cases. The American Journal of Pathology. 1942;**18**:

Winter WJ. Follicular lymphoma: A re-evaluation of its position in the scheme of malignant lymphoma,

[9] Hicks EB, Rappaport H,

Heilkd. 1898;**19**:21-90

[6] Sternberg C. Uber eine eigenartige unter dem Bilde der Pseudoleukamic

[1] Kumar V, Abbas AK, Aster Robbins JC. Diseases of white blood cells, lymph nodes, spleen, and thymus. In: Robbins and Cotran Pathologic Basis of Disease. 9th ed. Philadelphia:

Elsevier; 2015. pp. 579-628

pp. 1861-1878

1832;**17**:68-114
